Bioactive vegetable proteins and peptides in lipid-lowering; nutraceutical potential

Keyphrases

• Bile Acid Metabolism 33%
• Bile Acids 33%
• Bioactive 100%
• Blood Cholesterol 33%
• Cardiovascular Disease 100%
• Cardiovascular Risk Factors 33%
• Cause of Death 33%
• Cholesterol 33%
• Cholesterol Biosynthesis 33%
• Cholesterol Levels 66%
• Chronic Disease Burden 33%
• Concentrate Protein 33%
• Deficiency Diseases 33%
• Developed Countries 33%
• Diet Therapy 33%
• Dietary Change 33%
• Disease Management 33%
• Disease Progression 33%
• Drug Combination 33%
• Drug Costs 33%
• Dyslipidemia 33%
• Food Drugs 33%
• Functional Food 33%
• Global Burden 33%
• Health Benefits 33%
• Hypercholesterolemia 33%
• Infectious Diseases 33%
• Inpatient Treatment 33%
• Lipid Levels 33%
• Lipid-lowering Therapy 100%
• Lipids 33%
• Natural Drugs 33%
• Number of Drugs 33%
• Nutraceutical Potential 100%
• Nutraceuticals 33%
• Nutritional Deficiency 33%
• Optimal Dose 33%
• Pharmaceutical Management 33%
• Plasma Cholesterol 33%
• Prescription Drugs 33%
• Primary Risk 33%
• Protein Concentrate 33%
• Protein Hydrolysate 100%
• Protein-peptide Complex 100%
• Reduced Absorption 33%
• Risk Factors for Cardiovascular Diseases 33%
• Vegetable Protein 100%
• Vegetables 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Bile Acid 40%
• Cardiovascular Disease 100%
• Cholesterol 100%
• Chronic Disease 20%
• Combination Drug 20%
• Diseases 40%
• Dyslipidemia 20%
• Functional Food 100%
• Hypercholesterolemia 20%
• Infection 20%
• Lipid 100%
• Nutritional Deficiency 20%
• Peptide 60%
• Peptides and Proteins 100%
• Protein Hydrolysate 60%